skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi guys,

Once we get through this virus, which vacation/cruise/hotel/entertainment companies in North America would be of interest to you!!!

Jim
Read Answer Asked by jim on December 21, 2020
Q: commonly, all of these stocks seem to be in sectors that are doing well i know there are many more are there any sectors that you might particularly favour this upcoming year?
Read Answer Asked by terrance on December 21, 2020
Q: I have a considerable base of my portfolio in CDN banks. The share prices are approximately flat from where I bought them. Is there any catalyst to make banks outperform in the next year or 2? It feels like there have to be sectors that will bounce well with a recovery and wondering about diverting some funds there to try to catch the bounce on a return to travel and the like. I have nibbled at Air Canada and wonder about some other names that have a high likelihood of surviving and bouncing nicely. Canada or US, moderate risk is OK. Thanks!
Read Answer Asked by Marilou on December 21, 2020
Q: Morning Peter / Ryan and Team, first, Thanks so much for your calming advice through this past / current period of turmoil ! I am soon going to retire and start drawing on my rsp for income after years of accumulation. Thanks again to your guidance!!
This brings about some questions.
First, from a performance aspect, would a person be better using Drips and then selling stock to fund withdrawals, or, cancel drips and let dividends fund the withdrawals?
Second, when evaluating a stock/etf for an income portfolio, should more importance be put on dividend or growth? I have an all equity portfolio, diversified geographically and sector wise as per your recommendations, intend to stay in equity, simply increase cash reserves to fund withdrawals and allow a cushion. Thanks, Lavern
p.s. Happy Holidays to all, and Stay Safe! Better 6' apart than 6' under!!
Read Answer Asked by Lavern on December 21, 2020
Q: Hi Peter and team:
Just a note to say thank you. Two points: First, I sent in a question which I thought was almost an unfair one and virtually impossible. You actually answered it and provided your methodology with exactly what I needed. Second, I submitted my question late Friday, thinking I wouldn't receive an answer until Monday or so. I open up my email Saturday morning to find a reply time stamped at 2:00 am. Wow...needless to say, you made my day.
Thanks for the great service...above and beyond!
Please take Christmas Day off...Steve
Read Answer Asked by Stephen on December 21, 2020
Q: May I have your opinion on this stock? I looks like it has some potential. Merry Christmas
Read Answer Asked by Margot on December 21, 2020
Q: In a reply to a question from Vinod on Dec. 14th, you referred to a "DOG investigation".
What kind of an animal is this ?

Jacques IDS
Read Answer Asked by Jacques on December 21, 2020
Q: Both of these has been hitting all time highs.
Looks like STNE passed the 20B market cap and kept going. Any thoughts on valuation?
Re Okta looking to add to round out the position. Worth waiting for it to settle down or things looks good into 2021 and beyond so good as any time to hit the buy button. Maybe the recent cyber attack is helping here.

Thanks
Read Answer Asked by Sal on December 21, 2020
Q: Good morning 5i, question for you on prospects for Portage Biotech for growth, a friend of mine who was an earlier investor in this company, really likes the space and specifically the Chairman and Director Greg Bailey as he said he has a great track record with previous companies.

This is from Portage's site (CEO of Juvanescence. Managing Partner of Palantir Group, Inc, co-founder of Ascent Healthcare Solutions, VirnetX Inc. (Biohaven (BHVN:NYSE), and DuraMedic Inc. He was the initial financier and an independent Director of Medivation, Inc. (MDVN:NASDAQ), from 2005 to 2012. He also served as the Managing Director and co-Head of Life Sciences at MDB Capital Group LLC from May 2004 to December 2006.)

Do you know of Greg and would you feel comfortable with his history? I am guessing you do not know much about the company and in the biotech/cancer space there is tons of risk so that is fully understood, but looking to add to that sector for long term growth 15 plus years out.
Read Answer Asked by Michael on December 21, 2020
Q: Good morning 5i.
Yesterday I asked a question about options and you replied that one of your favourite strategies is to sell a call and a put on the same stock. I suppose I could run a few examples to try to see how this works. But, perhaps the best is to ask you to expand on that strategy a bit. Any particular things you look at in this strategy?
Read Answer Asked by joseph on December 21, 2020
Q: My 18-year-old daughter is interested in the stock market and wants to understand the value of owning stocks. She is looking to follow 6 stocks. She has some post-secondary aspirations for next year and would like your suggestions on 3 stable and 3 growth-oriented companies that you would buy today. Thanks
Read Answer Asked by kevin on December 21, 2020
Q: A little while ago, Stephen asked a question about some Reits and BSR was mentioned. In your answer, you suggest it was not cheap, based on 22x cash flow. A couple of questions: would other matrices also show it to be not cheap? About P/E, it shows at 5 on my Portfolio Tracking, but on the web page from my booker, it says 12.49....why the difference? Last, while I do like the business focus of BSR, CAP Reit is often mentioned favourably for this sector; can you briefly compare these 2 and suggest which you would prefer, and why? Thank you for your excellent service.
Read Answer Asked by Leonard on December 21, 2020